MedTrace Logo

Effects of Retinoids on CYP2D6 Activity During Pregnancy

NCT03117660 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 82

Last updated 2022-11-04

No results posted yet for this study

Summary

Prospective drug interaction study during pregnancy.

Conditions

  • CYP2D6 Polymorphism

Interventions

DRUG

Vitamin A

vitamin A daily X3-4 weeks

Sponsors & Collaborators

Principal Investigators

  • Mary F Hebert, PharmD · University of Washington

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-07-25
Primary Completion
2022-10-31
Completion
2022-10-31
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03117660 on ClinicalTrials.gov